These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 34147957)
1. Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world. Bustos J; Gonzales I; Saavedra H; Handali S; Garcia HH; J Neurol Sci; 2021 Aug; 427():117527. PubMed ID: 34147957 [TBL] [Abstract][Full Text] [Related]
2. High frequency of Taenia solium antigen positivity in patients admitted for neurological disorders in the Rural Hospital of Mosango, Democratic Republic of Congo. Mukendi D; Kalo JL; Lutumba P; Barbé B; Jacobs J; Yansouni CP; Gabriël S; Dorny P; Chappuis F; Boelaert M; Winkler AS; Verdonck K; Bottieau E BMC Infect Dis; 2021 Apr; 21(1):359. PubMed ID: 33865327 [TBL] [Abstract][Full Text] [Related]
3. New understanding about the relationship among neurocysticercosis, seizures, and epilepsy. Carpio A; Romo ML; Hauser WA; Kelvin EA Seizure; 2021 Aug; 90():123-129. PubMed ID: 33632613 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania: a diagnostic accuracy study. Stelzle D; Makasi CE; Schmidt V; Van Damme I; Trevisan C; Ruether C; Fleury A; Noh J; Handali S; Dorny P; Magnussen P; Zulu G; Mwape KE; Bottieau E; Gabriël S; Ngowi BJ; Winkler AS; Lancet Infect Dis; 2024 Jan; 24(1):98-106. PubMed ID: 37660709 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence and risk factors of human cysticercosis and taeniasis prevalence in a highly endemic area of epilepsy in Bangoua, west Cameroon. Nkouawa A; Dschanou AR; Moyou-Somo R; Sako Y; Ito A Acta Trop; 2017 Jan; 165():116-120. PubMed ID: 26747010 [TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of cysticercosis and neurocysticercosis]. Bouteille B Med Sante Trop; 2014; 24(4):367-74. PubMed ID: 25296005 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of and contributors to neurocysticercosis in endemic regions. Ta R; Blond BN J Neurol Sci; 2022 Oct; 441():120393. PubMed ID: 36054944 [TBL] [Abstract][Full Text] [Related]
11. Neurocysticercosis with symptomatic epilepsy manifestation. Nekrasova N; Tovazhnyanska O; Sushetska D; Markovska O; Shapkin A; Singh R; Soloviova Y; Butov D Med Glas (Zenica); 2021 Aug; 18(2):444-449. PubMed ID: 34190505 [TBL] [Abstract][Full Text] [Related]
16. New developments in the management of neurocysticercosis. White AC J Infect Dis; 2009 May; 199(9):1261-2. PubMed ID: 19358667 [No Abstract] [Full Text] [Related]
17. Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management. Winkler AS Pathog Glob Health; 2012 Sep; 106(5):261-74. PubMed ID: 23265550 [TBL] [Abstract][Full Text] [Related]
18. Neurocysticercosis: Diagnostic problems & current therapeutic strategies. Rajshekhar V Indian J Med Res; 2016 Sep; 144(3):319-326. PubMed ID: 28139530 [TBL] [Abstract][Full Text] [Related]
19. Neurocysticercosis in a rural population with extensive pig production in Angónia district, Tete Province, Mozambique. Assane YA; Trevisan C; Schutte CM; Noormahomed EV; Johansen MV; Magnussen P Acta Trop; 2017 Jan; 165():155-160. PubMed ID: 26519884 [TBL] [Abstract][Full Text] [Related]